$317 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 10 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 16.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PMVP | Sell | PMV PHARMACEUTICALS INC | $169,772,000 | -5.6% | 4,969,911 | -9.1% | 53.57% | +13.2% |
AI | Sell | C3.AIcl a | $54,199,000 | -40.7% | 866,774 | -37.5% | 17.10% | -28.9% |
REAL | THE REALREAL | $46,517,000 | -12.7% | 2,354,080 | 0.0% | 14.68% | +4.7% | |
GKOS | GLAUKOS CORP | $29,382,000 | +1.1% | 346,364 | 0.0% | 9.27% | +21.2% | |
EIGR | EIGER BIOPHARMACEUTICALS INC | $6,517,000 | -3.7% | 764,918 | 0.0% | 2.06% | +15.4% | |
AGTC | APPLIED GENETIC TECHNOL CORP | $5,492,000 | -22.9% | 1,404,515 | 0.0% | 1.73% | -7.5% | |
CDTX | CIDARA THERAPEUTICS INC | $2,741,000 | -24.1% | 1,356,813 | 0.0% | 0.86% | -8.9% | |
VERO | VENUS CONCEPT INC | $2,048,000 | +32.3% | 658,657 | 0.0% | 0.65% | +58.7% | |
XENE | XENON PHARMACEUTICALS INC | $148,000 | 0.0% | 8,293 | 0.0% | 0.05% | +20.5% | |
DARE | DARE BIOSCIENCE INC | $95,000 | +11.8% | 50,368 | 0.0% | 0.03% | +36.4% | |
Exit | OBALON THERAPEUTICS INC | $0 | – | -380,224 | -100.0% | -0.28% | – | |
STIM | Exit | NEURONETICS INC | $0 | – | -497,158 | -100.0% | -1.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-26
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
THE REALREAL | 18 | Q3 2023 | 62.6% |
KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
MACROGENICS INC | 14 | Q1 2020 | 19.2% |
PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-27 |
13F-HR | 2023-10-20 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-25 |
13F-HR | 2022-08-02 |
13F-HR | 2022-04-13 |
13F-HR | 2022-01-25 |
13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.